Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Understanding the use of diverted buprenorphine.
Cicero TJ, Ellis MS, Chilcoat HD. Cicero TJ, et al. Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12. Drug Alcohol Depend. 2018. PMID: 30359928 Free article.
Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.
Cicero TJ, Ellis MS, Kasper ZA. Cicero TJ, et al. Drug Alcohol Depend. 2017 Aug 1;177:101-103. doi: 10.1016/j.drugalcdep.2017.04.004. Epub 2017 May 30. Drug Alcohol Depend. 2017. PMID: 28582697
Factors contributing to the rise of buprenorphine misuse: 2008-2013.
Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. Cicero TJ, et al. Drug Alcohol Depend. 2014 Sep 1;142:98-104. doi: 10.1016/j.drugalcdep.2014.06.005. Epub 2014 Jun 18. Drug Alcohol Depend. 2014. PMID: 24984689
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.
Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Muñoz A. Cicero TJ, et al. Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):851-9. doi: 10.1002/pds.1113. Pharmacoepidemiol Drug Saf. 2005. PMID: 15892169
Abuse-deterrent Opioid Formulations.
Litman RS, Pagán OH, Cicero TJ. Litman RS, et al. Anesthesiology. 2018 May;128(5):1015-1026. doi: 10.1097/ALN.0000000000002031. Anesthesiology. 2018. PMID: 29252508 Review.
Do abuse deterrent opioid formulations work?
Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Dart RC, et al. J Opioid Manag. 2017 Nov/Dec;13(6):365-378. doi: 10.5055/jom.2017.0415. J Opioid Manag. 2017. PMID: 29308584 Review.
Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivation.
Ellis MS, Cicero TJ, Dart RC, Green JL. Ellis MS, et al. Among authors: cicero tj. Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):117-121. doi: 10.1002/pds.4687. Epub 2018 Nov 9. Pharmacoepidemiol Drug Saf. 2019. PMID: 30411819
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Vosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, Green JL. Vosburg SK, et al. J Pain. 2018 Apr;19(4):439-453. doi: 10.1016/j.jpain.2017.11.007. Epub 2017 Dec 7. J Pain. 2018. PMID: 29224919
217 results
Jump to page
Feedback